Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-25 @ 3:05 PM
NCT ID:
NCT00529568
Group ID:
EG001
Title:
Placebo+Antiviral Therapy: DB Phase
Description:
Participants completing the OL Phase were administered matching placebo tablets QD in combination with antiviral therapy (peginterferon alfa-2b and ribavirin) for a duration of either 24 or 48 weeks (for participants with Genotype 2/3) or 48 weeks (for participants with Non-Genotype 2/3).
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
49
Serious Number At Risk:
252
Other Number Affected:
226
Other Number At Risk:
252
Study:
NCT00529568
Results Section:
NCT00529568
Adverse Events Module:
NCT00529568